Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alignment Healthcare, Inc.ALHC · Entity 4269 | Chief Human Resources Officer | March 18, 2026 | March 19, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alignment Healthcare, Inc.
Report date March 18, 2026 · Filed March 19, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 148,628 |
Ending reported balance
After 2026-03-19 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-03-18 · Sale · Disposed 12,000 · Balance 160,230 F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Row 2 · 2026-03-19 · Sale · Disposed 11,602 · Balance 148,628 F3: Date of Rule 10b5-1 plan adoption: 11/21/2025 F4: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.18 to $18.30. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person.
F2: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
F3: Date of Rule 10b5-1 plan adoption: 11/21/2025
F4: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.18 to $18.30. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 19, 2026 Filed Mar 19, 2026 18:24 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 11,602 | $18.22 | $211,396.56 |
DisclosureSEC source: 0001628280-26-019906 · wk-form4_1773959086.xml · nonDerivative · entry 2 Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 148,628 F3 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.18 to $18.30. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 18, 2026 Filed Mar 19, 2026 18:24 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 12,000 | $17.84 | $214,080.00 |
DisclosureSEC source: 0001628280-26-019906 · wk-form4_1773959086.xml · nonDerivative · entry 1 Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 160,230 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $17.40 to $18.24. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 13, 2026 Filed Mar 17, 2026 17:24 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 23,543 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-018909 · wk-form4_1773782650.xml · nonDerivative · entry 1 Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 172,230 F1 · shares: Represents 23,543 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| March 04, 2026 Filed Mar 4, 2026 17:24 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 21,118 | $18.62 | $393,250.95 |
DisclosureSEC source: 0001628280-26-014737 · wk-form4_1772663046.xml · nonDerivative · entry 1 Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 148,687 F1 · kind: Date of Rule 10b5-1 plan adoption: 11/21/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $18.47 to $18.89. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| February 10, 2026 Filed Feb 10, 2026 21:51 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 22,238 | $20.47 | $455,211.86 |
DisclosureSEC source: 0001628280-26-007093 · wk-form4_1770778285.xml · nonDerivative · entry 1 Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,805 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted share units. This transaction does not represent a discretionary trade by the reporting person. Read SEC document |
| August 25, 2025 Filed Aug 25, 2025 17:41 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 12,032 | $16.47 | $198,167.04 |
DisclosureSEC source: 0002006326-25-000003 · wk-form4_1756158093.xml · nonDerivative · entry 1 Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 192,043 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/11/2025 Read SEC document |
| June 11, 2025 Filed Jun 13, 2025 16:32 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 19,399 | $15.26 | $296,042.32 |
DisclosureSEC source: 0001628280-25-031341 · wk-form4_1749846734.xml · nonDerivative · entry 1 Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 204,075 F1 · kind: Date of Rule 10b5-1 plan adoption: 03/11/2025 F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.00 to $15.45. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 19, 2025 Filed Mar 19, 2025 21:56 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 2,743 | $16.96 | $46,517.99 |
DisclosureSEC source: 0001628280-25-013968 · wk-form4_1742435788.xml · nonDerivative · entry 3 Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 223,474 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F5 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.73 to $17.12. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 19, 2025 Filed Mar 19, 2025 21:56 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,889 | $16.09 | $78,654.23 |
DisclosureSEC source: 0001628280-25-013968 · wk-form4_1742435788.xml · nonDerivative · entry 2 Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,217 F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. F4 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $15.73 to $16.72. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 18, 2025 Filed Mar 19, 2025 21:56 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 4,888 | $16.89 | $82,561.25 |
DisclosureSEC source: 0001628280-25-013968 · wk-form4_1742435788.xml · nonDerivative · entry 1 Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,106 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the grant of immediately vested common stock acquired on March 13, 2025 and reported on a Form 4 filed with the SEC on March 17, 2025. This transaction does not represent a discretionary trade by the reporting person. F2 · price: The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $16.85 to $16.93. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range. Read SEC document |
| March 13, 2025 Filed Mar 17, 2025 17:54 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 35,109 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-013215 · wk-form4_1742248437.xml · nonDerivative · entry 1 Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 235,994 F1 · shares: Represents (i) 25,806 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date; and (ii) 9,303 fully vested shares of Common Stock granted in lieu of cash settlement of the annual incentive award earned by the reporting person for the 2024 fiscal year. Read SEC document |
| February 12, 2025 Filed Feb 12, 2025 19:42 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | SaleCommon Stock | 14,878 | $14.38 | $213,945.64 |
DisclosureSEC source: 0001628280-25-005254 · wk-form4_1739407326.xml · nonDerivative · entry 1 Wagner Andreas P. · CIK 0002006326 · Chief Human Resources Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,885 F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This transaction does not represent a discretionary trade by the reporting person. Read SEC document |
| March 13, 2024 Filed Mar 15, 2024 20:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-004880 · doc4.xml · nonDerivative · entry 1 Wagner Andreas P. · CIK 0002006326 · Chief People Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 215,763 F1 · shares: Represents 60,000 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 18:00 UTC | Alignment Healthcare, Inc. ALHC · Entity 4269 | GrantCommon Stock | 155,763 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-003056 · doc4.xml · nonDerivative · entry 1 Wagner Andreas P. · CIK 0002006326 · Chief People & Culture Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,763 F1 · kind: Represents 155,763 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest 25% on each of the first four anniversaries of the grant date, subject to the reporting person's continued service to the Company on the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.